Olle Ringdén

56.4k citations
681 papers · 39.2k · 10 hit papers · h-index 91

Impact in

  • Hematology top 0.01%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Genetics top 0.01%
    • Mesenchymal stem cell research

Papers in

    • Hematopoietic Stem Cell Transplantation 373
    • Acute Myeloid Leukemia Research 67
    • T-cell and B-cell Immunology 77
    • Immune Cell Function and Interaction 65

Olle Ringdén

674 papers receiving 38.2k citations

Olle Ringdén's Hit Papers

Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines 2019 · 298 citations
2980+12+24Years since publication50010001.5k2.0k

Peers

Olle Ringdén
Comparison fields: 5 of 158
  • Hematology 16.6k
  • Genetics 13.4k
  • Transplantation 1.8k
  • Immunology 8.2k
  • Oncology 6.5k
Replace Andrea Bacigalupo with:
Andrea Bacigalupo Italy
Franco Locatelli Italy
Arnon Nagler Israel
Rainer Storb United States
Richard E. Champlin United States
Bruce R. Blazar United States
Éliane Gluckman France
Daniel J. Weisdorf United States
Hillard M. Lazarus United States
Jerome Ritz United States
Olle Ringdén relative to Andrea Bacigalupo Italy Andrea Bacigalupo's profile →
Citations per field
00.5×1.5×2.2×
Andrea Bacigalupo · 1×
Citations per year

Countries citing papers authored by Olle Ringdén

Since Specialization
Citations

This map shows the geographic impact of Olle Ringdén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olle Ringdén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olle Ringdén more than expected).

Fields of papers citing papers by Olle Ringdén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olle Ringdén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olle Ringdén. The network helps show where Olle Ringdén may publish in the future.

Co-authors

The 25 scholars most cited alongside Olle Ringdén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Olle Ringdén Line = papers co-authored together Olle Ringdén links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 681 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
Hit paper breakdown →
20042141
2
Graft-versus-leukemia reactions after bone marrow transplantation
Hit paper breakdown →
19902119
3
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
Hit paper breakdown →
20082041
4
HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells
Hit paper breakdown →
20031290
5
Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex
Hit paper breakdown →
20031081
6
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
Hit paper breakdown →
2006893
7
Immunomodulation by mesenchymal stem cells and clinical experience
Hit paper breakdown →
2007558
8
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
Hit paper breakdown →
2003519
9
Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
Hit paper breakdown →
2012425
10 2005416
11 2000401
12 2005349
13 2005336
14 2007331
15
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
Hit paper breakdown →
2019298
16 2012268
17 2000266
18 2004265
19 1990262
20 1994259

About Olle Ringdén

Olle Ringdén is a scholar working on Hematology, Immunology, Oncology, Epidemiology and Genetics, having authored 681 papers that have together received 39.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (373 papers), Mesenchymal stem cell research (87 papers), Cytomegalovirus and herpesvirus research (82 papers), T-cell and B-cell Immunology (77 papers), Acute Myeloid Leukemia Research (67 papers), Immune Cell Function and Interaction (65 papers), Acute Lymphoblastic Leukemia research (62 papers) and Renal Transplantation Outcomes and Treatments (52 papers). The work is most often cited by research in Hematology (16.6k citations), Genetics (13.4k citations), Transplantation (1.8k citations), Immunology (8.2k citations) and Oncology (6.5k citations). Olle Ringdén has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Katarina Le Blanc, Berit Sundberg, Mats Remberger, Per Ljungman, Ida Rasmusson, Mehmet Uzunel, Jonas Mattsson, Cecilia Götherström, B Lönnqvist and Moustapha Hassan. Their work appears in journals such as Bone Marrow Transplantation, Blood, Transplantation, Biology of Blood and Marrow Transplantation and Scandinavian Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact